Sign In
Buy LEGN
$35.98
-0.300 (-0.83%)
At Close: Jun 03, 2026
Biotech Shares Have Soared Since 2020's Wave of IPOs
09:45am, Wednesday, 17'th Feb 2021
Indicative of investors' enthusiasm for new biotechs, the average gain in share price for the top 10 companies of the sector that went public in 2020 now tops 100%.
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel c
SOMERSET, N.J.--(BUSINESS WIRE)-- #LegendBiotech--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and devel
Week In Review: Week's China Life Science Investments Total $800 Million
03:01pm, Sunday, 20'th Dec 2020
Overland Pharmaceuticals will form a $117 million China JV with Allogene Therapeutics to bring allogenic CAR-T drugs to China. Harbour BioMed has out-licensed its fully human SARS-CoV-2 neutralizing a
Legend Biotech to Participate in the 39th Annual J.P. Morgan Healthcare Conference
04:30pm, Tuesday, 15'th Dec 2020
SOMERSET, N.J.--(BUSINESS WIRE)-- #JPM2021--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development
Legend Biotech Added to the NASDAQ Biotechnology Index
04:30pm, Monday, 14'th Dec 2020
SOMERSET, N.J.--(BUSINESS WIRE)-- #biotech--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development
SOMERSET, N.J.--(BUSINESS WIRE)-- #LYMSM--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development o
ASH Annual Meeting: Drugmakers Battle for Multiple Myeloma
11:44am, Sunday, 13'th Dec 2020
Targeting BCMA is all the rage, but who will come out on top?
Here's the Hot Target for Multiple Myeloma Drugs
03:44pm, Saturday, 12'th Dec 2020
Drugmakers are targeting B-cell maturation antigen in different ways.
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel c
Legend Biotech Announces New Appointment to the Board of Directors and Resignation of Dr. Fangliang Zhang
07:00am, Monday, 23'rd Nov 2020
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel c
LEGEND BIO INVESTOR ALERT
10:18am, Sunday, 01'st Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Legend Bio To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp.
Arenas, stadiums find new life as safer options for voting
06:10pm, Thursday, 22'nd Oct 2020
ATLANTA (AP) - With long waits making headlines during early voting across the country, professional sports venues have emerged as bright spots, repurposing huge spaces mostly devoid of fans into effi
EA SPORTS NHL® 21 Featuring an Expanded Be A Pro Experience and New Hut Rush Mode Now Available Worldwide
12:00am, Friday, 16'th Oct 2020
Today, Electronic Arts Inc. (NASDAQ: EA) launched EA SPORTS™ NHL® 21, with a deeper and more authentic Be A Pro career experience and a fast, fun new
After bubble experiment, NHL turns to new ad tech to make up for missed revenue due to coronavirus
01:23pm, Thursday, 01'st Oct 2020
After completing it Covid-19 bubble in Canada, NHL Chief Business Officer Keith Wachtel tells CNBC that the league hopes to have its virtual advertisement technology for the 2021-22 season.
